The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity-Reference-Cited by-同舟云学术

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity

Published:2022-12 Issue:12 Volume:20 Page:2939-2952
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Smith Christopher W.^ORCID,Harbi Maan H.^ORCID,Garcia‐Quintanilla Lourdes^ORCID,Rookes Kieran^ORCID,Brown Helena^ORCID,Poulter Natalie S.^ORCID,Watson Steve P.^ORCID,Nicolson Phillip L.R.^ORCID,Thomas Mark R.^ORCID

Funder

British Heart Foundation

Novartis

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15899

Reference68 articles.

1. Long‐term use of ticagrelor in patients with prior myocardial infarction;Bonaca;N Engl J Med,2015

2. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

4. Novel antiplatelet targets in the treatment of acute coronary syndromes;Alenazy;Platelets,2021

5. Genetic and antibody‐induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl3‐induced thrombosis;Bender;J Thromb Haemost,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of HALP score in predicting mortality in non-ST-elevation myocardial infarction patients;Coronary Artery Disease;2024-08-02

2. Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction;Frontiers in Molecular Biosciences;2024-03-13

3. GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease;European Heart Journal - Cardiovascular Pharmacotherapy;2024-03-07

4. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT);Expert Opinion on Pharmacotherapy;2024-02-11

5. Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy;Journal of Thrombosis and Haemostasis;2023-11